Sign up to save your podcasts
Or
Share NRG-BR008, The "HERO" Breast Cancer Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NRG-BR008, The "HERO" Breast Cancer Trial
The NRG Oncology Podcast Co-hosts sit with NRG-BR008 "HERO" Study Co-PIs Dr. Lior Braunstein and Dr. Melissa Mitchell to discuss this study for low-risk HER2+ breast cancer. This study will test if HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation for patients with early-stage HER2+ breast cancer.
View all episodes
By NRG Oncology
5
1010 ratings
The NRG Oncology Podcast Co-hosts sit with NRG-BR008 "HERO" Study Co-PIs Dr. Lior Braunstein and Dr. Melissa Mitchell to discuss this study for low-risk HER2+ breast cancer. This study will test if HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation for patients with early-stage HER2+ breast cancer.
More shows like The NRG Oncology Podcast
View all
The Joe Rogan Experience
229,579 Listeners
The New Yorker Radio Hour
6,964 Listeners
Planet Money
30,719 Listeners
Marketplace
8,784 Listeners
Investing Insights
537 Listeners
Fantasy Footballers - Fantasy Football Podcast
29,447 Listeners
White Coat Investor Podcast
2,457 Listeners
The Daily
113,257 Listeners
The Indicator from Planet Money
9,559 Listeners
QuadShot News Podcast
61 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,205 Listeners
The Ezra Klein Show
16,482 Listeners
Plain English with Derek Thompson
2,250 Listeners
At The Beam
37 Listeners
Value Health Voices
5 Listeners